Generated by AI
Charles River Laboratories International, Inc. is a life sciences company that provides products and services supporting pharmaceutical and biotechnology research, drug discovery, non-clinical development, and safety assessment. Its Research Models and Services business supplies purpose-bred rodents and genetically defined research models, along with related services used in laboratory and preclinical studies. Through Discovery and Safety Assessment, the company conducts regulated and non-regulated in vitro, in vivo, and in silico studies, laboratory support, consulting, and program management for potential medicines. Its Manufacturing Solutions activities include microbial testing and biologics-related services that help address quality, contamination control, and development requirements. Charles River Laboratories International, Inc. serves pharmaceutical and biotechnology companies, government agencies, academic institutions, and other research organizations across international life sciences markets. Its integrated role connects early laboratory research with the testing and development processes required to advance medical products toward regulatory review.
Website251 Ballardvale Street
Wilmington, MA, 01887
United States
The latest articles about CRL.
Charles River Laboratories stock fell early Wednesday, though the medical research firm beat third-quarter forecasts.
Summary of Nov 4's posts. Generated by AI.
Summary of Jul 23's posts. Generated by AI.
Summary of Sep 11's posts. Generated by AI.
Investors talking about CRL also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.